This podcast features: Michiel E. Ultee, PhD, Chief Scientific Officer, Laureate Biopharma[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0046.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends…
Manufacturing
The Highs and Lows of Manufacturing a Biosimilar
This podcast features: Philip Ridley-Smith, Business Development Manager, Cobra Biologics [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0048.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting…
ROUNDTABLE: Bioconjugates – From Targets to Therapeutics
This podcast features: Chairperson: Alan C. Rigby, PhD, Vice President Research, ImClone Systems Speakers/Panelists: Dr James R. Prudent, President and Chief Executive Officer, Centrose Jason C. Brady, PhD, Director, Business Development, Conjugates and Cytotoxics, Lonza John Burt, Chief Executive Officer, PolyTherics Trishul P. Shah, Business Development Manager, PolyPeptide Group John M. Lambert, EVP & CSO, ImmunoGen, Inc[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Antibody%20Non-Antibody%20Mftg/TASCAM_0062.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25,…
Case Study: Scale-Up Strategy for Liver Stem Cell Therapy
This podcast features: Eric Halioua, MBA, co-founder and Chief Executive Officer, Promethera Biosciences [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Cell%20Therapy/TASCAM_0056.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and…
Defining Critical Parameters for Scale-Up and Process Control in Cell Therapy
This podcast features: Robert Shaw, Commercial Director, Stem Cell Initiative, EMD Millipore [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Cell%20Therapy/TASCAM_0054.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific…
ROUNDTABLE: Pfenex and Agila Biotech Biosimilars Joint Venture – The Convergence of Expression & Manufacturing Technology Harnessing the Emerging Market Opportunity
This podcast features: Dr. Bertrand Liang, Chief Executive Officer, Pfenex Inc Dr. Anand Iyer, Chief Executive Officer, Agila Biotech Encik Rizatuddin “Ritz†Ramli, Chief Executive Officer, Malaysian Bio-XCell Sdn Bhd Daniel Bauer, Commercial Executive, FlexFactory Facilities, Xcellerex, Inc, A GE Healthcare Company [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0045.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the…
Simpler and More Efficient Vaccine Manufacturing
This podcast features: Fabien Moncaubeig, Senior Application Specialist, ATMI LifeSciences [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Vaccines/TASCAM_0064.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting…
Biosimilars: Challenges and Solutions
This podcast features: Jeffrey Su, PhD, Chief Scientific Officer, Cytovance Biologics[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0047.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting…
Leveraging a CMO to Optimize the Financial and Operational Efficiency of an Emerging Cell Therapy Business
This podcast features: Dr. Robert Preti, President & Chief Scientific Officer, PCT Cell Therapy Services [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Cell%20Therapy/TASCAM_0055.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest…
ROUNDTABLE: Biosimilar Development Concerns – Collaboration, Capacity, and CMOs
This podcast features: Chairperson: Patti Seymour, Senior Consultant, BioProcess Technology Consultants Speaker/Panelists: Thomas J. Vanden Boom, Vice President, Global Biologics Research, Hospira Dr. Uwe Buecheler, Senior Vice President, Biopharmaceutical Operations, Boehringer Ingelheim Michiel E. Ultee, PhD, Chief Scientific Officer, Laureate Biopharma Richard Brudnick, Vice President, BD/M&A, BiogenIdec [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0049.mp3″] This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on…